The founder and curator of MSDF’s drug database reveals how it keeps you up to date with experimental and approved therapies in MS and related demyelinating diseases

In episodes 56 and 57 of the MS Discovery podcast, Gavin Giovannoni, MBBCH, PhD, and Timothy Vollmer, MD, discuss the first large-scale study of a drug showing some benefits in a progressive form of multiple sclerosis. The story goes back decades, as Stephen Hauser, MD, recently explained.

A conference in Cambridge, Massachusetts, outlined progress and challenges in turning computational modeling into actionable knowledge in MS and other brain disorders

Every Friday, MSDF editors use a curated PubMed search to link to every newly published MS-related paper. Here’s how we do it.